TREND OF INCIDENCE OF GASTRIC CANCER IN SISTAN AND BALUCHESTAN PROVINCE, IRAN
DOI:
https://doi.org/10.22159/ajpcr.2016.v9s3.14738Abstract
ABSTRACT
Objective: Gastric cancer is the fifth most common cancer and the third cause of death from cancers in the world and is known as the most deadly
cancer in Iran. Since the knowledge about the epidemiological situation and the trend of incidence of this cancer is essential to plan for the prevention
and treatment of cancer, this study was performed with the aim of investigating the epidemiological status, the rate and the trend of gastric cancer
incidence in Sistan and Baluchestan province.
Methods: This study was conducted using existing data and data extracted from the National Cancer Registry System and the Disease Management
Center of Iranian Ministry of Health between 2003 and 2008. Age-Standardized incidence rates (ASIR) were calculated using the world standard
population. The crude incidence rate was also computed. Cochran–Armitage test for linear trend was used for evaluation of the incidence trend.
Results: The number of 255 cases of gastric cancer occurred in the study period that 188 cases were in men and 67 in women. Accordingly, the
incidence of gastric cancer has had an ascending trend in Sistan and Baluchestan (p=0.00) and its incidence in men and women has changed to
1.18 and 2.73 in 2004 to 1.84 and 4.48 in 2008, respectively. Furthermore, with ageing, the incidence of gastric cancer has increased in both sexes and
its incidence was higher in men than women.
Conclusion: The incidence of gastric cancer has an increasing trend in Sistan and Baluchestan, hence, etiological surveys and programs of early
diagnosis are useful in this province to the reduce cancer.
Keywords: Incidence, Gastric cancer, Iran, Epidemiology.
Downloads
References
Ghoncheh M, Mirzaei M, Salehiniya H. Incidence and mortality of breast cancer and their relationship with the human development index (HDI) in the world in 2012. Asian Pac J Cancer Prev 2016;16(18):8439-43.
Mahdavifar N, Ghoncheh M, Pakzad R, Momenimovahed Z, Salehiniya H. Epidemiology, incidence and mortality of bladder cancer and their relationship with the development index in the world. Asian Pac J Cancer Prev 2016;17(1):381-6.
Pakzad R, Mohammadian-Hafshejani A, Mohammadian M, Pakzad I, Safiri S, Khazaei S, et al. Incidence and mortality of bladder cancer and their relationship with development in Asia. Asian Pac J Cancer Prev 2015;16(6):7365-74.
Belpomme D, Irigaray P, Sasco AJ, Newby JA, Howard V, Clapp R, et al. The growing incidence of cancer: Role of lifestyle and screening detection (review). Int J Oncol 2007;30(5):1037-49.
Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, Pakzad I, Salehiniya H. The incidence and mortality of lung cancer and their relationship to development in Asia. Transl Lung Cancer Res 2015;4(6):763-74.
Pakzad R, Mohammadian-Hafshejani A, Ghoncheh M, Pakzad I, Salehiniya H. The incidence and mortality of prostate cancer and its relationship with development in Asia. Prostate Int 2015;3(4):135-40.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://www.globocan.iarc.fr. [Last accessed on 2014 Jul 31].
Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132(5):1133-45.
Naus JI. Clustering of random points in two dimensions. Biometrika 1965;52(1-2):263-7.
Hemminki K, Sundquist J, Ji J. Familial risk for gastric carcinoma: An updated study from Sweden. Br J Cancer 2007;96(8):1272-7.
Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods Mol Biol 2009;472:467-77.
Akbari MR, Malekzadeh R, Nasrollahzadeh D, Amanian D, Sun P, Islami F, et al. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer 2006;119(5):1047-51.
Foschi R, Lucenteforte E, Bosetti C, Bertuccio P, Tavani A, La Vecchia C, et al. Family history of cancer and stomach cancer risk. Int J Cancer 2008;123(6):1429-32.
Asmarian N, Kavousi A, Salehi M. Mapping of stomach cancer rate in Iran using area-to-area poisson kriging. J Health Syst Res 2012;9(3):681-7.
Roshanaei G, Sadighi S, Safari M, Faradmal J. Estimated survival time in gastric cancer patients and its associated factors. Koomesh 2012;14(1):47-54.
Kasakura Y, Phan A, Ajani J. Adjuvant therapy for resected gastric carcinoma. Surg Oncol Clin N Am 2002;11(2):431-44, xii-xiii.
Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006;12(3):354-62.
Khedmat H, Panahian M, Amini M. Survivsl of stomach cancer among patients hospitalized in Baghiatollah hospital. Teb Nezami 2007;9:167-77.
Roushanaei GA, Kazemnejad A, Sedighi S. Postoperative survival estimation of gastric cancer patients in cancer institute of Tehran, Imam Khomeini hospital and its relative factors. Sci J Hamadan Univ 2010;17:13-8.
Gunderson LL, Sosin H. Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982;8(1):1-11.
Goya M. Iranian Annual Cancer Registration Report 2005/2006. Ministry of Health and Medical Education, Health Deputy. Center for Disease Control and Prevention, 2007.
Razi S1, Rafiemanesh H, Ghoncheh M, Khani Y, Salehiniya H. changing trends of types of skin cancer in Iran. Asian Pac J Cancer Prev 2015;16(12):4955-8.
Razi S, Enayatrad M, Mohammadian-Hafshejani A, Salehiniya H, Fathali-Loy-Dizaji M, Soltani S. The epidemiology of skin cancer and its trend in Iran. Int J Prev Med 2015;6:64.
Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International Classification of Diseases for Oncology. Geneva, Switzerland: World Health Organization; 2000.
Pakzad R, Rafiemanesh H, Ghoncheh M, Sarmad A, Salehiniya H, Hosseini S, et al. Prostate cancer in Iran: Trends in incidence and morphological and epidemiological characteristics. Asian Pac J Cancer Prev 2016;17(2):839-43.
Borji A, Bayat M, Shamsabadi F, Amini F, Dayyani M, Majd HM. Epidemiology of gastrointestinal cancers (stomach, esophageal and colorectal) in Neyshabur city during 2006-2012. J Neyshabur Univ Med Sci 2016;3(4):37-44.
Almasi Z, Rahmati L, Alimoradi K, Eshrati B, Shamsi M. Epidemiological study of gastrointestinal cancers (gastric, esophageal, colorectal) in Markazi province in the years 1390-1385. J Neyshabur Univ Med Sci 2014;2(2):22-7.
Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric cancer in Iran: Epidemiology and risk factors. Arch Iran Med 2009;12(6):576-83.
Zahedi A, Rafiemanesh H, Enayatrad M, Ghoncheh M, Salehiniya H. Incidence, trends and epidemiology of cancers in north west of Iran. Asian Pac J Cancer Prev 2015;16(16):7189-93.
Almasi Z, Rafiemanesh H, Salehiniya H. Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran. Asian Pac J Cancer Prev 2015;16(7):2757-61.
Rafiemanesh H, Mehtarpoor M, Mohammadian-Hafshejani A, Salehiniya H, Enayatrad M, Khazaei S. Cancer epidemiology and trends in Sistan and Baluchestan province, Iran. Med J Islam Repub Iran 2015;29:254.
Uemura N, Okamoto S, Yamamoto S. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345(11):784-9.
Zendehdel N, Nasseri-Moghaddam S, Malekzadeh R, Massarrat S, Sotoudeh M, Siavoshi F. Helicobacter pylori reinfection rate 3 years after successful eradication. J Gastroenterol Hepatol 2005;20(3):401-4.
Matsuzaka M, Fukuda S, Takahashi I, Shimaya S, Oyama T, Yaegaki M, et al. The decreasing burden of gastric cancer in Japan. Tohoku J Exp Med 2007;212(3):207-19.
Enayatrad M, Amoori N, Salehiniya H. Epidemiology and trends inbreast cancer mortality in Iran. Iran J Public Health 2015;44(3):430-1.
Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94(2):153-6.
GarcÃa-Esquinas E, Pérez-Gómez B, Pollán M, Boldo E, Fernández-Navarro P, Lope V, et al. Gastric cancer mortality trends in Spain, 1976-2005, differences by autonomous region and sex. BMC Cancer 2009;9:1.
Stracci F, Canosa A, Minelli L, Petrinelli AM, Cassetti T, Romagnoli C, et al. Cancer mortality trends in the Umbria region of Italy 1978-2004: A joinpoint regression analysis. BMC Cancer 2007;7:10.
Abdirad A, Ghaderi-Sohi S, Shuyama K, Koriyama C, Nadimi-Barforoosh H, Emami S, et al. Epstein-Barr virus associated gastric carcinoma: A report from Iran in the last four decades. Diagn Pathol 2007;2:25.
Rahimi F, Heidari M. Time trend analysis of stomach cancer incidence in the west of Iran. J Health Dev 2012;1(2):100-11.
Kim J. Protective effects of Asian dietary items on cancers - soy and ginseng. Asian Pac J Cancer Prev 2008;9(4):543-8.
Ramesht MH, Pourfarzi F, Entezari M, Karamati H. An epidemiologic study of spatial and temporal patterns of gastric cancer in Ardabil (years 2006-2012). Health Mag 2015;6(3):345-54.
Biglarian AH, Govhari M, Khodabakhshi R. Survival analysis of patients withgastric cancer and its related factors. Kosar Med J Neyshabur Univ Med Sci 2008;12(4):345-35.
Roshanaei G, Kazemnejad A, Sadighi S. Survival estimating following recurrence in gastric cancer patients and its relative factors. Koomesh 2011;12(3):223-8.
Rajaiefard A, Moghimi B, Tabatabaie SH, Safaie A, Tabeie SZ. Epidemiological and clinical features of gastric cancer: Study documented cases of cancer in Fars province (2001-2006). South Med J 2011;2(14):14-21.
Rafiemanesh H, Rajaei-Behbahani N, Khani Y, Hosseini S, Pournamdar Z, Mohammadian-Hafshejani A, et al. Incidence trend and epidemiology of common cancers in the center of Iran. Glob J Health Sci 2015;8(3):146-55.
Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2(9):533-43.
Mosavi-Jarrahi A, Mohagheghi MA, Zeraatti H, Mortazavi H. Cancer registration in Iran Asian pacific. J Cancer Prev IARC Suppl 2001;2:25-9.
Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S. Oesophageal cancer studies in the Caspian littoral of Iran: The Caspian cancer registry. Br J Cancer 1973;28(3):197-214.
Farhadifar N, Keyhanian, SH, Z Fotoukian, Pouya M, Saravi M. Epidemiologic and malignancy indices of gastric cancer in patients referred to oncology clinic at ramsar emam sajjad hospital during 2002-2009. SSU J 2012;20(1):110-8.
Reza M. Gastric cancer in Iran. Digestion 2008;2(13):107-12.
Derakhshan MH, Liptrot S, Paul J, Brown IL, Morrison D, McColl KE. Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut 2009;58(1):16-23.
Erkisi M, Colakoglu S, Köksal F, Tuncer I, Burgut R, Karaköse H, et al. Relationship of Helicobacter pylori infection to several malignant and non-malignant gastrointestinal diseases. J Exp Clin Cancer Res 1997;16(3):289-93.
González CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European prospective investigation into cancer and nutrition (EPIC). J Natl Cancer Inst 2006;98(5):345-54.
Stanley K, Stjernswärd J, Koroltchouk V. Cancers of the stomach, lung and breast: Mortality trends and control strategies. World Health Stat Q 1987;41(3-4):107-14.
Haj-Sheykholeslami A, Rakhshani N, Amirzargar A, Rafiee R, Shahidi SM, Nikbin B, et al. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: Comparative study with type and severity of gastritis. Clin Gastroenterol Hepatol 2008;6(2):174-9.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
